SEMA3F and ductal breast carcinoma in situ: In summary, our results indicate that SEMA3F overexpression in MCF10DCIS.com leads to a more invasive phenotype and behavior in vitro and in vivo in this mild-aggressive cell line, suggesting that SEMA3F might promote DCIS progression to IDC.